Page 5 - Phase Labs News Today

Investment analysts at StockNews.com began coverage on shares of ProPhase Labs (NASDAQ:PRPH – Get Rating) in a research note issued on Wednesday. The brokerage set a “strong-buy” rating on the stock. A number of other brokerages also recently issued reports on PRPH. HC Wainwright lowered their price objective on ProPhase Labs from $16.00 to $14.00 […]

ProPhase Labs (NASDAQ: PRPH) has recently received a number of price target changes and ratings updates: 6/14/2022 – ProPhase Labs is now covered by analysts at StockNews.com. They set a “sell” rating on the stock. 6/7/2022 – ProPhase Labs was upgraded by analysts at TheStreet from a “c+” rating to a “b” rating. 6/6/2022 – […]

DIDI jumped on the potential end of a regulatory probe. Solar stocks rose on tariff relief. PRAX dropped on clinical data. PRPH added to its 52-week high.

Analysts expect that ProPhase Labs, Inc. (NASDAQ:PRPH – Get Rating) will post $18.05 million in sales for the current fiscal quarter, Zacks Investment Research reports. Two analysts have provided estimates for ProPhase Labs’ earnings, with the lowest sales estimate coming in at $13.39 million and the highest estimate coming in at $22.70 million. ProPhase Labs […]

Wall Street brokerages expect ProPhase Labs, Inc. (NASDAQ:PRPH – Get Rating) to report earnings per share of $0.17 for the current quarter, according to Zacks. Two analysts have issued estimates for ProPhase Labs’ earnings, with the highest EPS estimate coming in at $0.21 and the lowest estimate coming in at $0.12. ProPhase Labs reported earnings […]

StockNews.com assumed coverage on shares of ProPhase Labs (NASDAQ:PRPH – Get Rating) in a report released on Saturday. The firm set a “sell” rating on the stock. Several other equities research analysts have also commented on PRPH. TheStreet lowered shares of ProPhase Labs from a “b-” rating to a “c+” rating in a research note […]

ProPhase Labs (NASDAQ:PRPH – Get Rating) had its price objective reduced by research analysts at HC Wainwright from $16.00 to $14.00 in a research report issued on Monday, The Fly reports. HC Wainwright’s target price would suggest a potential upside of 89.45% from the stock’s current price. A number of other brokerages also recently weighed […]

ProPhase Labs, Inc. (NASDAQ:PRPH – Get Rating) was the target of a large drop in short interest in the month of April. As of April 15th, there was short interest totalling 71,000 shares, a drop of 31.2% from the March 31st total of 103,200 shares. Based on an average trading volume of 25,000 shares, the […]

Equities research analysts forecast that ProPhase Labs, Inc. (NASDAQ:PRPH – Get Rating) will post sales of $24.31 million for the current fiscal quarter, according to Zacks Investment Research. Two analysts have made estimates for ProPhase Labs’ earnings. The highest sales estimate is $32.05 million and the lowest is $16.57 million. ProPhase Labs posted sales of […]

Equities analysts expect ProPhase Labs, Inc. (NASDAQ:PRPH – Get Rating) to post $0.39 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for ProPhase Labs’ earnings, with estimates ranging from $0.30 to $0.47. ProPhase Labs posted earnings per share of $0.23 during the same quarter last year, which […]